PUBLICATION

Acteoside protects against 6-OHDA-induced dopaminergic neuron damage via Nrf2-ARE signaling pathway

Authors
Li, M., Zhou, F., Xu, T., Song, H., Lu, B.
ID
ZDB-PUB-180616-11
Date
2018
Source
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association   119: 6-13 (Journal)
Registered Authors
Keywords
Acteoside, Nrf2, Parkinson's disease, The blood-brain-barrier, Zebrafish
MeSH Terms
  • Animals
  • Antioxidants/metabolism
  • Carboxylic Ester Hydrolases/genetics
  • Carboxylic Ester Hydrolases/metabolism*
  • Dopaminergic Neurons/drug effects*
  • Gene Expression Regulation, Enzymologic/drug effects
  • Glucosides/pharmacology*
  • Larva
  • Malondialdehyde/metabolism
  • Metabolic Networks and Pathways/drug effects
  • Motor Activity/drug effects
  • NF-E2-Related Factor 2/genetics
  • NF-E2-Related Factor 2/metabolism*
  • Oxidopamine/toxicity*
  • Phenols/pharmacology*
  • Zebrafish
  • Zebrafish Proteins/genetics
  • Zebrafish Proteins/metabolism*
PubMed
29906474 Full text @ Food Chem. Toxicol.
CTD
29906474
Abstract
Acteoside has been reported to have antioxidant and neuroprotective effect, which is a promising therapeutic way in prevention and treatment of Parkinson's disease. The present study was aimed to understand the neuroprotective effect of acteoside and to elucidate its underlying mechanism. 6-hydroxydopamine (6-OHDA)-induced neural damage in zebrafish model was used to study the protective effect of acteoside on Parkinson disease (PD). Locomotion behavioral test showed that acteoside could prevent 6-OHDA-stimulated movement disorders. Anti-tyrosine hydroxylase (TH) whole-mount immunostaining analysis showed that acteoside could prevent 6-OHDA-induced dopaminergic neuron death. In addition, pretreatment with acteoside could upregulate antioxidative enzymes by activating the Nrf2/ARE signaling pathway in zebrafish. Meanwhile, acteoside was found to be distributed in the brain after intraperitoneal injection into the adult zebrafish, indicating that this compound could penetrate the blood-brain-barrier (BBB). This study demonstrated that acteoside could penetrate BBB and have potential therapeutic value for Parkinson's disease by activating the Nrf2/ARE signaling pathway and attenuating the oxidative stress.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping